To follow up on some of the observations made in the previous section, we measured the phosphoproteome of the FGFR2-overexpressing and FGFR2 inhibitor-sensitive rhabdoid sarcoma line G401 (Fig. 3B,C) in response to Infigratinib in a time-dependent fashion. The gene discussed is FGFR2; the disease is rhabdoid tumor.